In Part I of this series, we reported that SIDS infants have altered 5-HT2A/C binding in key medullary nuclei supporting chemoreception, arousal, and autoresuscitation, in addition to altered 5-HT1A binding reported previously (47). The gene discussed is HTR2A; the disease is sudden infant death syndrome.